RP had found the HER2 link before. What is new is
Post# of 148190
“Expression of CCR5 associated with HER2 in circulating tumor cells (CTCs)”
CTC is associated with cancer metastasis. So this new CTC connection gives stronger evidence that a CCR5 inhibitor can help with the HER2 population, because a CCR5 inhibitor will make it harder for these HER2 positive cancer cells to become circulating to begin with.